# Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndrome

> **NCT07736144** · NA · RECRUITING · sponsor: **Juan Jiao** · enrollment: 60 (estimated)

## Conditions studied

- Fibromyalgia Syndrome

## Interventions

- **DRUG:** Yangyin Roujin Decoction
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT07736144
- **Lead sponsor:** Juan Jiao
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2027-12-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07736144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07736144, "Mechanism Study of Yangyin Roujin Formula in the Treatment of Fibromyalgia Syndrome". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07736144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*